Friday 6 November 2026 Export ANIP’s income statement to Excel — free account

ANI Pharmaceuticals, Inc.

ANIP Healthcare Drug Manufacturers Specialty & Generic

ANI Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $883.4 million, up 43.8% from fiscal 2024.

Revenue: +27.6%
EPS: +29.4%
Free cash flow: +85.5%
Total debt: −96.2%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

68.56 1.06 −1.52%

Follow ANIP

Alert me

Market cap: $1.6B
P/E: 13.3×
Fwd P/E: 14.3×
Dividend yield: —
F-score: 7/9
Altman Z: 2.30
Beneish M: −2.62
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	7	7	8	7	+8 more TTM periods Free account
ROE Full definition →	20.45%	20.88%	18.63%	16.34%
ROA Full definition →	7.85%	7.61%	6.73%	5.66%
ROIC Full definition →	46.43%	11.30%	9.10%	8.05%
Return on Tangible Assets Full definition →	17.82%	17.56%	15.90%	14.36%
Average Days of Receivables Full definition →	106.71	102.40	100.93	116.14
Free Cash Flow per Share Full definition →	9.68	7.92	8.74	7.53
Free Cash Flow Full definition →	205.32	167.52	182.81	150.90
Capital Expenditures Full definition →	(23.87)	(21.94)	(25.80)	(34.32)
Other line items
Cash ROIC Full definition →	18.72%	10.58%	12.17%	10.39%
Accounts Receivable Turnover Full definition →	3.74	3.91	3.88	3.51
Accounts Payable Turnover Full definition →	5.62	6.03	5.90	6.31
Inventory Turnover Full definition →	2.87	2.75	2.58	2.44
Average Days of Payables Full definition →	66.98	69.56	70.30	66.93
Days of Inventory on Hand Full definition →	122.77	134.87	144.71	153.00
Tax Rate Full definition →	(0.26)	(0.24)	(0.21)	(0.18)
Research and Development Expense of Revenue Full definition →	4.86%	5.10%	5.60%	5.85%
Selling, General and Administrative Expense of Revenue Full definition →	32.94%	33.19%	34.09%	35.97%
Share Based Compensation of Revenue Full definition →	4.13%	4.20%	4.25%	4.29%
Interest Coverage Full definition →	11.19	9.09	6.75	5.54
Operating CF/Net income Full definition →	1.96	1.75	2.28	2.40
Depreciation/Fixed assets Full definition →	0.00	1.17	1.33	1.46
Capex/Depreciation Full definition →	0.00	(0.26)	(0.29)	(0.38)
Revenue per Share Full definition →	49.09	46.24	44.17	44.05
Operating CF per Share Full definition →	10.81	8.95	9.97	9.24
Capex per Share Full definition →	(1.13)	(1.04)	(1.23)	(1.71)
Capex to Sales Full definition →	0.02	0.02	0.03	0.04

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly